<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0009">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Brown</surname>
    <given-names>A. J.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Won</surname>
    <given-names>J. J.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Graham</surname>
    <given-names>R. L.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Dinnon III</surname>
    <given-names>K. H.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sims</surname>
    <given-names>A. C.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Feng</surname>
    <given-names>J. Y.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Cihlar</surname>
    <given-names>T.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Denison</surname>
    <given-names>M. R.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Baric</surname>
    <given-names>R. S.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Sheahan</surname>
    <given-names>T. P.</given-names>
   </name>
  </person-group> (
  <year>2019</year>). 
  <article-title>Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase</article-title>. 
  <source>
   <italic>Antiviral Research</italic>
  </source>, 
  <volume>169</volume>, 
  <fpage>104541</fpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2019.104541</pub-id>
  <pub-id pub-id-type="pmid">31233808</pub-id>
 </mixed-citation>
</ref>
